Ponikau Jens U, Sherris David A, Kephart Gail M, Adolphson Cheryl, Kita Hirohito
Department of Otorhinolaryngology, University at Buffalo, The State University of New York, Buffalo, NY, USA.
Clin Rev Allergy Immunol. 2006 Jun;30(3):187-94. doi: 10.1385/CRIAI:30:3:187.
Chronic rhinosinusitis (CRS) is a confusing disease for both allergists and otorhinolaryngologists, partly because of its poorly understood pathophysiology and partly because of its limited treatment options. Several recent reports have provided evidence for a better understanding of the etiology and the relationship of CRS to airborne fungi-especially to Alternaria. First, the development of novel methods enables detection of certain fungi in mucus from the nasal and paranasal sinus cavities. Second, a non-IgE-mediated immunological mechanism for reactivity of patients with CRS to certain common fungi has been described. Third, these fungi are surrounded by eosinophils in vivo, suggesting that they are targeted by eosinophils. Finally, the preliminary results of studies using antifungal agents to treat patients with CRS are promising. Overall, these recent discoveries provide a logical mechanism for the pathophysiology of CRS, and they also suggest promising avenues for treatment of CRS with antifungal agents.
慢性鼻-鼻窦炎(CRS)对于过敏症专科医生和耳鼻咽喉科医生来说都是一种令人困惑的疾病,部分原因是其病理生理学尚未得到充分理解,部分原因是其治疗选择有限。最近的几份报告为更好地理解CRS的病因及其与空气传播真菌——尤其是链格孢属真菌的关系提供了证据。首先,新方法的开发使得能够检测鼻和鼻窦腔黏液中的某些真菌。其次,已经描述了CRS患者对某些常见真菌产生反应的非IgE介导的免疫机制。第三,这些真菌在体内被嗜酸性粒细胞包围,表明它们是嗜酸性粒细胞的靶向目标。最后,使用抗真菌药物治疗CRS患者的研究初步结果很有前景。总体而言,这些最新发现为CRS的病理生理学提供了一个合理的机制,也为用抗真菌药物治疗CRS指明了有前景的途径。